BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
  • Home
  • Chronic Pain Claims
    • CRPS Compensation
    • Fibromyalgia Compensation
    • Myofascial Pain Syndrome Compensation
    • Somatic Symptom Disorder Compensation
    • Neuropathic Pain Compensation
    • Functional Neurological Disorder Compensation
    • Chronic Pain Syndrome Compensation
  • Case Studies
  • Chronic Pain Blog
  • Testimonials
  • Contact Us

Home » Could spider venom hold the key to treating chronic pain?

Rehabilitation and Treatment Feb 11th, 2022
Venomous spider

Could spider venom hold the key to treating chronic pain?

Visit our comprehensive Chronic Pain information hub.

It may be counterintuitive to associate animal venom of any kind with developments in the treatment of chronic pain. However, five years ago, we reported on the discovery of the pain-relieving benefits of a compound known as Rg1A, which is found in the venom of a type of predatory sea snail. Laboratory tests on rats confirmed that injecting the compound not only relieved pain, but that its effects were relatively long-lasting compared to other drug therapies. Another benefit is that Rg1A is non-addictive. In light of these discoveries, it seems surprising that little has been heard of Rg1A since.

Now, researchers in Australia have published a paper on another compound, Pm1a, found in the venom of the rather terrifyingly-named King Baboon Spider. While not fatal, its bite is extremely painful, and the effects can last for several days. Breaking down the venom into its various components, the team believes that one of them – Pm1a – is responsible for its potency. It appears that Pm1a plays a significant role in our brain feeling pain through the central nervous system. The mechanism by which it achieves this is technical but put simply, Pm1a acts on multiple ion channels in the body, causing pain neurons to continue firing repeatedly.

The team says that understanding this mechanism could lead to new drug therapies that inhibit the excitability of the neurons in these channels, reducing or even eliminating pain.

Andrew Atkinson
Make an Enquiry

Contact Us

Contact Form

Left Column

Right Column

Centre

 
Sending

Recent Articles

  • The law on accessible toilets
  • Taking medication abroad
  • CRPS and excessive sweating
  • The importance of medical records in your CRPS compensation claim
  • CRPS and sleep

Share this Article

Newsletter Sign-up

* indicates required

Legal Glossary

Find Out More

You may also like...

  • Sep 9th, 2021
    WaveWriter Alpha: new generation SCS
    Read Article
  • Jun 28th, 2022
    What is multidisciplinary pain management?
    Read Article
View All Related Articles

Get in Touch Today

Contact Form

Left Column

Right Column

Centre

 
Sending

1 Edgar Buildings,
George Street,
Bath, BA1 2DU

01225 462871 01225 445060
Authorised & Regulated by Solicitors Regulation Authority (No. 636644).
©2025 BLB Solicitors  |  Privacy & Terms